Published in J Clin Oncol on April 01, 1994
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother (1998) 1.43
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis. J Clin Microbiol (2003) 1.11
Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother (1997) 0.95
Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study. PLoS Med (2016) 0.92
Emerging Issues in Nosocomial Fungal Infections. Curr Infect Dis Rep (1999) 0.88
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin. J Clin Microbiol (2013) 0.78
Practical modalities for prevention of fungal infections in cancer patients. Eur J Clin Microbiol Infect Dis (1997) 0.76
Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits. Antimicrob Agents Chemother (1999) 0.75
Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria. Eur J Clin Microbiol Infect Dis (2013) 0.75
Nonsense codons and polarity in the tryptophan operon. J Mol Biol (1966) 6.40
Compilation, alignment, and phylogenetic relationships of DNA polymerases. Nucleic Acids Res (1993) 5.31
A new strategy for multifunction myoelectric control. IEEE Trans Biomed Eng (1993) 5.17
Autophosphorylation sites on the epidermal growth factor receptor. Nature (1984) 5.11
Regulation of the enzymes of the tryptophan pathway in Escherichia coli. Genetics (1965) 4.92
The MDM2 gene amplification database. Nucleic Acids Res (1998) 4.64
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med (1989) 4.20
Bacteriophage PRD1 DNA polymerase: evolution of DNA polymerases. Proc Natl Acad Sci U S A (1987) 3.77
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
The acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.49
Nucleotide sequence of the major early region of bacteriophage phi 29. Gene (1982) 3.26
Amino acid replacements and the genetic code. Cold Spring Harb Symp Quant Biol (1966) 3.03
Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II). J Clin Invest (1965) 3.00
The nature of the anthranilic acid synthetase complex of Escherichia coli. J Biol Chem (1966) 2.89
Limited periods of gene expression in immunoglobulin-synthesizing cells. Science (1969) 2.77
Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med (1984) 2.60
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 2.55
Relation between sexual practices and T-cell subsets in homosexually active men. Lancet (1983) 2.46
Clinical use of the 193-nm excimer laser in the treatment of corneal scars. Arch Ophthalmol (1991) 2.41
Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosom Med (1996) 2.40
Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry (1993) 2.38
THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS. J Clin Invest (1961) 2.32
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol (1989) 2.27
Bacteriophage phi29 terminal protein: its association with the 5' termini of the phi29 genome. J Virol (1978) 2.20
Identification of the protein firmly bound to the ends of bacteriophage phi 29 DNA. Virology (1978) 2.18
Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med (1991) 2.17
Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol (1999) 2.15
The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature (1987) 2.14
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol (1987) 2.11
Antibodies and immunoglobulins. II. Normal development and changes in disease. JAMA (1965) 2.10
CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr (1989) 2.10
The immunoglobulins of mice. VI. Response to immunization. J Immunol (1965) 2.08
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Role of DNA and specific cytoplasmic receptors in glucocorticoid action. Proc Natl Acad Sci U S A (1972) 1.97
Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Clin Immunol Immunopathol (1983) 1.91
Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res (1996) 1.91
Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol (1998) 1.90
Anthranilate synthetase, an enzyme specified by the tryptophan operon of Escherichia coli: Comparative studies on the complex and the subunits. J Bacteriol (1969) 1.89
Early effects of HIV on CD4 lymphocytes in vivo. J Immunol (1987) 1.87
Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol (1993) 1.86
DNA replication of bacteriophage phi 29: characterization of the intermediates and location of the termini of replication. Virology (1980) 1.82
T5 DNA polymerase: structural--functional relationships to other DNA polymerases. Proc Natl Acad Sci U S A (1989) 1.80
Nucleotide sequences at the termini of phi 29 DNA. Proc Natl Acad Sci U S A (1981) 1.76
A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis (1990) 1.75
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood (2000) 1.74
Increased rate of asporogenous mutations following treatment of Bacillus subtilis spores with ethyl methanesulfonate. Mutat Res (1971) 1.74
The use of the 193-nm excimer laser for myopic photorefractive keratectomy in sighted eyes. A multicenter study. Arch Ophthalmol (1991) 1.73
Recruitment and retention of participants in prevention trials involving family-based interventions. Am J Prev Med (2001) 1.73
Studies on the fresh water cercariae in Leyte Island, Philippines. 4. Cercariae from Viviparidae and Pilidae. Jpn J Exp Med (1977) 1.71
A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry (1990) 1.71
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med (1990) 1.71
Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet (2000) 1.71
Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility. Dev Biol (1996) 1.71
Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol (1998) 1.69
Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A (2001) 1.68
Retracted Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science (2001) 1.67
Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol (1998) 1.65
Polarity in the tryptophan operon of E. coli. Cold Spring Harb Symp Quant Biol (1966) 1.65
Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant (2000) 1.62
Optimism is associated with mood, coping, and immune change in response to stress. J Pers Soc Psychol (1998) 1.55
Occupational injuries among minors doing farm work in Washington State: 1986 to 1989. Am J Public Health (1992) 1.55
CT and MR imaging of the "target sign" in metastatic brain disease. Eur Radiol (2000) 1.54
Use of insoluble antibody for quantitative determination of small amounts of immunoglobulin. J Immunol (1969) 1.51
Early blocked asporogenous mutants of Bacillus subtilis 168. I. Isolation and characterization of mutants resistant to antibiotic(s) produced by sporulating Bacillus subtilis 168. Mol Gen Genet (1971) 1.50
Human lymphocyte membrane (HL-A) alloantigens: isolation, purification and properties. J Immunol (1969) 1.50
Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS (1991) 1.50
Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J Immunol (1984) 1.49
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer. J Surg Oncol (2009) 1.49
Anthranilate synthetase, an enzyme specified by the tryptophan operon of Escherichia coli: purification and characterization of component I. J Bacteriol (1969) 1.48
Oncocytic lipoadenoma of the submandibular gland. Hum Pathol (1998) 1.48
Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem (1997) 1.47
Monocytoid B-cell lymphoma. Am J Surg Pathol (1989) 1.47
Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46
Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system. J Clin Immunol (1985) 1.46
Normal immunoglobulins and antibody response in neonatally thymectomized mice. J Natl Cancer Inst (1965) 1.45
Evidence for several cell populations active in antibody dependent cellular cytotoxicity. J Immunol (1973) 1.44
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann N Y Acad Sci (1971) 1.43
Synthesis of immunoglobulins by human cell lines in tissue culture. J Immunol (1967) 1.42
The complete sequence of the Bacillus phage phi 29 right early region. Gene (1985) 1.41
The separation of DNA segments attached to proteins. Anal Biochem (1979) 1.40
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum. J Nat Prod (2001) 1.39
Replication of bacteriophage phi 29 DNA in vitro: the roles of terminal protein and DNA polymerase. Proc Natl Acad Sci U S A (1984) 1.39
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
The difficult patient: creation of a curriculum by third-year family practice residents. Fam Med (1996) 1.37
Analysis of phi 29 and phi 15 genomes by bacterial restriction endonucleases, EcoR1 and Hpal. Virology (1976) 1.35
Abortive infection of sporulating Bacillus subtilis 168 by phi 2 bacteriophage. J Virol (1971) 1.35
Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. J Immunol (1987) 1.34
Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008) 1.33
In vitro complex formation between bacteriophage phi 29 terminal protein and deoxynucleotide. Biochem Biophys Res Commun (1982) 1.33
Vagal stimulation and cardiac slowing. J Auton Nerv Syst (1984) 1.32
The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med (1992) 1.32
The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. Blood (1997) 1.32
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood (2000) 1.32
Ability of nucleus cochlear implantees to recognize music. Ann Otol Rhinol Laryngol (1999) 1.30
In vitro replication of bacteriophage phi 29 DNA. Proc Natl Acad Sci U S A (1982) 1.29
Pleiotropic nature of bacteriophage tolerant mutants obtained in early-blocked asporogenous mutants of Bacillus subtilis 168. Mol Gen Genet (1973) 1.29